Literature DB >> 24700175

Association between upper digestive tract microbiota and cancer-predisposing states in the esophagus and stomach.

Guoqin Yu1, Mitchell H Gail, Jianxin Shi, Vanja Klepac-Ceraj, Bruce J Paster, Bruce A Dye, Guo-Qing Wang, Wen-Qiang Wei, Jin-Hu Fan, You-Lin Qiao, Sanford M Dawsey, Neal D Freedman, Christian C Abnet.   

Abstract

BACKGROUND: The human upper digestive tract microbial community (microbiota) is not well characterized and few studies have explored how it relates to human health. We examined the relationship between upper digestive tract microbiota and two cancer-predisposing states, serum pepsinogen I/pepsinogen II ratio (PGI/II; predictor of gastric cancer risk) and esophageal squamous dysplasia (ESD; the precursor lesion of esophageal squamous cell carcinoma; ESCC) in a cross-sectional design.
METHODS: The Human Oral Microbe Identification Microarray was used to test for the presence of 272 bacterial species in 333 upper digestive tract samples from a Chinese cancer screening cohort. Serum PGI and PGII were determined by ELISA. ESD was determined by chromoendoscopy with biopsy.
RESULTS: Lower microbial richness (number of bacterial genera per sample) was significantly associated with lower PGI/II ratio (P = 0.034) and the presence of ESD (P = 0.018). We conducted principal component (PC) analysis on a β-diversity matrix (pairwise difference in microbiota), and observed significant correlations between PC1, PC3, and PGI/II (P = 0.004 and 0.009, respectively), and between PC1 and ESD (P = 0.003).
CONCLUSIONS: Lower microbial richness in upper digestive tract was independently associated with both cancer-predisposing states in the esophagus and stomach (presence of ESD and lower PGI/II). IMPACT: These novel findings suggest that the upper digestive tract microbiota may play a role in the etiology of chronic atrophic gastritis and ESD, and therefore in the development of gastric and esophageal cancers. ©2014 AACR.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24700175      PMCID: PMC4011942          DOI: 10.1158/1055-9965.EPI-13-0855

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  31 in total

1.  Molecular characterization of the stomach microbiota in patients with gastric cancer and in controls.

Authors:  Johan Dicksved; Mathilda Lindberg; Magnus Rosenquist; Helena Enroth; Janet K Jansson; Lars Engstrand
Journal:  J Med Microbiol       Date:  2009-04       Impact factor: 2.472

2.  Extensive gastric atrophy: an increased risk factor for superficial esophageal squamous cell carcinoma in Japan.

Authors:  Katsunori Iijima; Tomoyuk Koike; Yasuhiko Abe; Yoshifumi Inomata; Hitoshi Sekine; Akira Imatani; Naoki Nakaya; Shuichi Ohara; Tooru Shimosegawa
Journal:  Am J Gastroenterol       Date:  2007-05-03       Impact factor: 10.864

Review 3.  Environmental causes of esophageal cancer.

Authors:  Farin Kamangar; Wong-Ho Chow; Christian C Abnet; Sanford M Dawsey
Journal:  Gastroenterol Clin North Am       Date:  2009-03       Impact factor: 3.806

4.  Serum pepsinogens and risk of gastric and oesophageal cancers in the General Population Nutrition Intervention Trial cohort.

Authors:  J-S Ren; F Kamangar; Y-L Qiao; P R Taylor; H Liang; S M Dawsey; B Liu; J-H Fan; C C Abnet
Journal:  Gut       Date:  2009-01-09       Impact factor: 23.059

5.  Serum pepsinogens and risk of esophageal squamous dysplasia.

Authors:  Farin Kamangar; Lena Diaw; Wen-Qiang Wei; Christian C Abnet; Guo-Qing Wang; Mark J Roth; Bing Liu; Ning Lu; Carol Giffen; You-Lin Qiao; Sanford M Dawsey
Journal:  Int J Cancer       Date:  2009-01-15       Impact factor: 7.396

6.  Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases.

Authors:  Daniel N Frank; Allison L St Amand; Robert A Feldman; Edgar C Boedeker; Noam Harpaz; Norman R Pace
Journal:  Proc Natl Acad Sci U S A       Date:  2007-08-15       Impact factor: 11.205

7.  Cytologic detection of esophageal squamous cell carcinoma and its precursor lesions using balloon samplers and liquid-based cytology in asymptomatic adults in Llinxian, China.

Authors:  Qin-Jing Pan; Mark J Roth; Hui-Qin Guo; Michael L Kochman; Guo-Qing Wang; Michael Henry; Wen-Qiang Wei; Carol A Giffen; Ning Lu; Christian C Abnet; Chang-Qing Hao; Philip R Taylor; You-Lin Qiao; Sanford M Dawsey
Journal:  Acta Cytol       Date:  2008 Jan-Feb       Impact factor: 2.319

8.  Comparisons of subgingival microbial profiles of refractory periodontitis, severe periodontitis, and periodontal health using the human oral microbe identification microarray.

Authors:  Ana Paula V Colombo; Susan K Boches; Sean L Cotton; J Max Goodson; Ralph Kent; Anne D Haffajee; Sigmund S Socransky; Hatice Hasturk; Thomas E Van Dyke; Floyd Dewhirst; Bruce J Paster
Journal:  J Periodontol       Date:  2009-09       Impact factor: 6.993

9.  A core gut microbiome in obese and lean twins.

Authors:  Peter J Turnbaugh; Micah Hamady; Tanya Yatsunenko; Brandi L Cantarel; Alexis Duncan; Ruth E Ley; Mitchell L Sogin; William J Jones; Bruce A Roe; Jason P Affourtit; Michael Egholm; Bernard Henrissat; Andrew C Heath; Rob Knight; Jeffrey I Gordon
Journal:  Nature       Date:  2008-11-30       Impact factor: 49.962

10.  The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing.

Authors:  Les Dethlefsen; Sue Huse; Mitchell L Sogin; David A Relman
Journal:  PLoS Biol       Date:  2008-11-18       Impact factor: 8.029

View more
  42 in total

1.  Microbial characterization of esophageal squamous cell carcinoma and gastric cardia adenocarcinoma from a high-risk region of China.

Authors:  Dantong Shao; Emily Vogtmann; Anqi Liu; Junjie Qin; Wen Chen; Christian C Abnet; Wenqiang Wei
Journal:  Cancer       Date:  2019-07-29       Impact factor: 6.860

Review 2.  The Esophageal Microbiome in Health and Disease.

Authors:  Brooke Corning; Andrew P Copland; Jeanetta W Frye
Journal:  Curr Gastroenterol Rep       Date:  2018-08-01

Review 3.  International cancer seminars: a focus on esophageal squamous cell carcinoma.

Authors:  G Murphy; V McCormack; B Abedi-Ardekani; M Arnold; M C Camargo; N A Dar; S M Dawsey; A Etemadi; R C Fitzgerald; D E Fleischer; N D Freedman; A M Goldstein; S Gopal; M Hashemian; N Hu; P L Hyland; B Kaimila; F Kamangar; R Malekzadeh; C G Mathew; D Menya; G Mulima; M M Mwachiro; A Mwasamwaja; N Pritchett; Y-L Qiao; L F Ribeiro-Pinto; M Ricciardone; J Schüz; F Sitas; P R Taylor; K Van Loon; S-M Wang; W-Q Wei; C P Wild; C Wu; C C Abnet; S J Chanock; P Brennan
Journal:  Ann Oncol       Date:  2017-09-01       Impact factor: 32.976

Review 4.  The human gastric microbiota: Is it time to rethink the pathogenesis of stomach diseases?

Authors:  Gerardo Nardone; Debora Compare
Journal:  United European Gastroenterol J       Date:  2015-06       Impact factor: 4.623

5.  A Comparison of Biopsy and Mucosal Swab Specimens for Examining the Microbiota of Upper Gastrointestinal Carcinoma.

Authors:  An-Qi Liu; Emily Vogtmann; Dan-Tong Shao; Christian C Abnet; Hao-Yu Dou; Yu Qin; Zheng Su; Wen-Qiang Wei; Wen Chen
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2019-09-13       Impact factor: 4.254

Review 6.  Emerging Insights into the Esophageal Microbiome.

Authors:  Michael May; Julian A Abrams
Journal:  Curr Treat Options Gastroenterol       Date:  2018-03

Review 7.  Molecular mechanisms of ethanol-associated oro-esophageal squamous cell carcinoma.

Authors:  Yao Liu; Hao Chen; Zheng Sun; Xiaoxin Chen
Journal:  Cancer Lett       Date:  2015-03-09       Impact factor: 8.679

Review 8.  The role of intestinal bacteria in the development and progression of gastrointestinal tract neoplasms.

Authors:  Kosuke Mima; Shuji Ogino; Shigeki Nakagawa; Hiroshi Sawayama; Koichi Kinoshita; Ryuichi Krashima; Takatsugu Ishimoto; Katsunori Imai; Masaaki Iwatsuki; Daisuke Hashimoto; Yoshifumi Baba; Yasuo Sakamoto; Yo-Ichi Yamashita; Naoya Yoshida; Akira Chikamoto; Takatoshi Ishiko; Hideo Baba
Journal:  Surg Oncol       Date:  2017-07-21       Impact factor: 3.279

Review 9.  The hallmarks of premalignant conditions: a molecular basis for cancer prevention.

Authors:  Bríd M Ryan; Jessica M Faupel-Badger
Journal:  Semin Oncol       Date:  2015-09-08       Impact factor: 4.929

Review 10.  Mechanistic and Technical Challenges in Studying the Human Microbiome and Cancer Epidemiology.

Authors:  Mukesh Verma
Journal:  Technol Cancer Res Treat       Date:  2016-06-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.